HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A novel suicide gene therapy targeting the overexpression of eukaryotic initiation factor 4E improves survival in a rat peritoneal carcinomatosis model.

AbstractBACKGROUND:
Eukaryotic Initiation Factor 4E (eIF4E) is pivotal in translating mRNAs with complex 5' un-translated regions (UTRs). A target-specific gene therapy was developed by splicing a complex 5'UTR upstream of the herpes simplex virus thymidine kinase (TK) gene in an adenovirus vector (Ad-HSV-UTK). Translation of the suicide TK gene is restricted to cells that overexpress eIF4E. We investigated the efficacy of this novel therapy in a rat peritoneal carcinomatosis (PC) model.
METHODS:
A PC model was developed by implanting a syngeneic 0.25 cm(3) tumor into Fisher 344 rats' omentum. Rats were grouped as follow: No surgery (Ø CS), cytoreductive surgery alone (CS), and CS + Ad-HSV-UTK + gancyclovir (GCV). 10(9) Ad-HSV-UTK was injected intraperitoneally (i.p.) and GCV (50 mg/kg) was administered i.p. every other day, beginning on postoperative day 2. The Kaplan-Meier survival method and log-rank test were statistical tests used.
RESULTS:
Treated rats had a significantly longer median and overall survival than the Ø CS and CS groups (P = .012). The median survivals for the treated rats, Ø CS, CS were 18 days, 9 days, and 11 days, respectively.
CONCLUSIONS:
Treatment with a novel suicide gene therapy following cytoreductive surgery prolonged survival in a rat peritoneal carcinomatosis model.
AuthorsKerry Byrnes, Benjamin D L Li, Neal Holm, Jie Li, Yoshi Okadata, Arrigo De Benedetti, A Nedeljkovic-Kurepa, Michael Mathis, Quyen D Chu
JournalSurgery (Surgery) Vol. 142 Issue 2 Pg. 270-5 (Aug 2007) ISSN: 0039-6060 [Print] United States
PMID17689695 (Publication Type: Journal Article)
Chemical References
  • Antiviral Agents
  • Eukaryotic Initiation Factor-4E
  • Ganciclovir
Topics
  • Adenocarcinoma (surgery, therapy)
  • Adenoviridae (genetics)
  • Animals
  • Antiviral Agents (pharmacology)
  • Cell Line, Tumor
  • Combined Modality Therapy
  • Disease Models, Animal
  • Eukaryotic Initiation Factor-4E (genetics)
  • Female
  • Ganciclovir (pharmacology)
  • Gene Expression Regulation, Neoplastic
  • Genes, Transgenic, Suicide
  • Genetic Therapy (methods)
  • Mammary Neoplasms, Animal (surgery, therapy)
  • Neoplasm Transplantation
  • Neoplasm, Residual (surgery, therapy)
  • Omentum
  • Peritoneal Neoplasms (surgery, therapy)
  • Rats
  • Rats, Inbred F344
  • Survival Rate

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: